Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

1. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46(2):328-346.

2. Majithia V, Geraci SA. Rheumatoid arthritis: Diagnosis and management. Am J Med 2007;120:936-939.

3. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol 2000;27(3):630-637.

4. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907-916.

5. Kotzin BL. The role of B cells in the pathogenesis of rheumatoid arthritis. J Rheumatol 2005;73(Suppl):14-18.

6. Lipsky PE. Rheumatoid arthritis. In: Kasper DL, Braunwald E, Fauci AS, et al., eds. Harrison's Online, 16th ed. New York: McGraw-Hill, 2005.

7. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician 2005;72(6):1037-1047.

8. Juvenile Arthritis Fact Sheet. Arthritis Foundation.

9. Vital EM, Emery P. The development of targeted therapies in rheumatoid arthritis. J Autoimmun 2008;31:219-227.

10. Gonzalez A, Icen M, Kremers HM, et al. Mortality trends in rheumatoid arthritis: The role of rheumatoid factor. J Rheumatol 2008;35:1009-1014.

11. Dhawan SS, Quyyumi AA. Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep 2008;10(2):128-133.

12. Magnano MD, Genovese MC. Management of co-morbidities and general medical conditions in patients with rheumatoid arthritis. Curr Rheumatol Rep 2005;7(5):407-415.

13. Panoulas VF, Metsios GS, Pace AV, et al. Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2008;47(9):1286-1298.

14. Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analysis from a large US observational study. Arthritis Rheum 2007;56:2886-2895.

15. Chakravarty EF, Genovese MC. Associations between rheumatoid arthritis and malignancy. Rheum Dis Clin North Am 2004;30(2): 271-284.

16. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA 2005;294:1671-1684.

17. Wallace CA. Current management of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2006;20:279-300.

18. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59(6):762-784.

O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004;350:2591-2602.

Naesdal J, Brown K. NSAID-associated adverse effects and acid control aids to prevent them. A review of current treatment options. Drug Saf 2006;29(2):119-132.

Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids—New mechanisms for old drugs. N Engl J Med 2005;353:1711-1723.

Ohsugi Y, Kishimoto T. The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis. Expert Opin Biol Ther 2008;8(5):669-681.

Cronstein BN. Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 2005;57(2):163-172.

van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double blind, randomized, placebo-controlled trial. Arthritis Rheum 2007; 56(5):1424-1432.

Niehues T, Lankisch P. Recommendations for the use of methotrexate in juvenile idiopathic arthritis. Paediatr Drugs 2006;8:347-356.

Cannon GW, Kremer JM. Leflunomide. Rheum Dis Clin North Am 2004;30(2):295-309.

Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis 2003; 62(Suppl 2):ii13-ii16.

Genovese MC, Kremer JM. Treatment of rheumatoid arthritis with etanercept. Rheum Dis Clin North Am 2004;30(2):311-328.

Cush JJ. Safety overview of new disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 2004;30(2):237-255.

Maini SR. Infliximab treatment of rheumatoid arthritis. Rheum Dis Clin North Am 2004;30(2):329-347.

Keystone E, Haraoui B. Adalimumab therapy in rheumatoid arthritis. Rheum Dis Clin North Am 2004;30(2):349-364.

Todd DJ, Costenbader KH, Weinblatt ME. Abatacept in the treatment of rheumatoid arthritis. Int J Clin Pract 2007;61(3):494-500.

33. Panayi GS. B cell-directed therapy in rheumatoid arthritis—Clinical experience. J Rheumatol 2005;32(Suppl 73):19-24.

34. Smolen JS, Keystone EC, Emery P, et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66(2):143-150.

35. Keystone E, Fleischmann R, Emery P, et al. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis. Arthritis Rheum 2007; 56(12):3896-3908.

36. Raj DS. Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum 2009;38:382-388.

37. Emery P, Keystone E, Tony HP, et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-TNF biologics: Results from a 24-week multicentre randomised placebo controlled trial. Ann Rheum Dis 2008;67:1516-1523.

38. Rychly DJ, DiPiro JT. Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 2005;25:1181-1192.

39. Curtis JR, Patkar N, Xie A, et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007;56(4):1125-1133.

40. Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-2285.

41. Janssen NM, Genta MS. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 2000;160:610-619.

42. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-735.

43. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: A review of its history, issues, progress, and documentation. J Rheumatol 2003;30(1):167-178.

44. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: Dimensions and practical applications. Health Qual Life Outcomes 2003;1(1):20.

45. van der Heijde D, van't Hof MA, van Riel PL, et al. Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score. Ann Rheum Dis 1990;49(11):916-920.

46. Recommendations for the prevention and treatment of glucocorticoids-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee in Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001;44:1496-1503.

58 Osteoarthritis

Steven M. Smith, Benjamin J. Epstein, and John G. Gums


Was this article helpful?

0 0
Treating Rheumatoid Arthritis With Herbs Spices Roots

Treating Rheumatoid Arthritis With Herbs Spices Roots

Did You Know That Herbs and Spices Have Been Used to Treat Rheumatoid Arthritis Successfully for Thousands of Years Do you suffer with rheumatoid arthritis Would you like to know which herbs and spices naturally reduce inflammation and pain 'Treating Rheumatoid Arthritis with Herbs, Spices and Roots' is a short report which shows you where to start.

Get My Free Ebook

Post a comment